Citi cuts AppLovin target price to $500 from $600
APP•Citi cut its target price for AppLovin to $500 from $600.
Related News
Bioxytran completes production of two dietary supplements
BIXT•
Cousins Properties target price cut to $32 from $35 by BMO
CUZ•
Summit Therapeutics opens Phase II trial of ivonescimab regimens in advanced kidney cancer
SMMT•
SpaceX spectrum deal reinforces need for terrestrial towers, Gravis says
SPCX•
Cullinan's zipalertinib shows 30.2% intracranial response rate in Phase 2 lung cancer trial
CGEM•